Alnylam to webcast presentation at canaccord genuity 45th annual growth conference

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will present a company overview at the canaccord genuity 45th annual growth conference, on tuesday, august 12, 2025 at 8:00 am et. a live audio webcast of the presentation will be available on the investors section of the company's website, www.alnylam.com/events. a replay will be available on the alnylam website within 48 hours after the event.
ALNY Ratings Summary
ALNY Quant Ranking